Mounjaro (tirzepatide) has become a powerful tool for many adults managing type 2 diabetes, and its strong weight-loss effects have driven demand far beyond its original approval. Without insurance coverage, the price can feel overwhelming for people who need it month after month. That out-of-pocket cost is one of the biggest barriers patients face when considering or continuing treatment.
As of 2026, the list price for a single four-week supply of Mounjaro typically sits around $1,000–$1,100 before any discounts or assistance programs. This figure comes straight from Eli Lilly’s wholesale acquisition cost and reflects what pharmacies charge cash-paying customers. Real-world prices vary slightly depending on location, pharmacy, and whether you use a discount card.
The good news is that several legitimate savings pathways exist even for those without insurance or with plans that exclude coverage. Understanding the full pricing picture—list cost, common discounts, manufacturer programs, and alternative options—helps you plan realistically and avoid surprises at the pharmacy counter.
Mounjaro’s List Price Without Insurance
The manufacturer’s list price for one carton of Mounjaro (four prefilled pens, one-month supply) hovers between $1,060 and $1,135 in most U.S. regions in 2026. This amount is the same across all four strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
Pharmacies add their own dispensing fees, which can push the cash price slightly higher—sometimes $1,100–$1,200 depending on the chain or independent store. Prices tend to be lowest at large chains with competitive cash-pay programs and highest at smaller independent pharmacies.
This list price does not reflect what most insured patients actually pay after coverage, copay cards, or assistance. For uninsured individuals, though, it is the starting point before any savings are applied.
How Much Does Mounjaro Cost Without Insurance?
Without any form of coverage or discount, a 28-day supply of Mounjaro costs approximately $1,060–$1,135 at retail pharmacies across the United States in 2026. That breaks down to roughly $265–$285 per weekly injection when paying full price.
Prices can fluctuate by $50–$100 depending on your ZIP code, the specific pharmacy, and whether you purchase through a large chain, specialty pharmacy, or online mail-order service. Urban areas with more competition sometimes offer slightly lower cash prices than rural regions.
This full retail cost applies whether you are completely uninsured, have a plan that excludes Mounjaro, or are in the deductible phase of your coverage. It represents the highest amount you would pay before exploring assistance options.
Eli Lilly’s Savings Card for Commercially Insured Patients
Eli Lilly offers a savings card that dramatically reduces costs for eligible commercially insured patients who do not have government coverage (Medicare, Medicaid, VA, etc.). With the card, most people pay $25 for a 1-month or 3-month supply, subject to maximum annual savings limits (typically $150 per fill, up to $1,800 per year as of 2026).
The card is not available to uninsured patients or those with government plans. It works at most retail pharmacies and requires activation through the NovoCare or Lilly website or by calling the support line.
Eligibility rules are strict: you must have private insurance, the prescription must be for an approved indication (type 2 diabetes), and you cannot combine it with other federal or state assistance programs. Always verify current terms directly with Lilly because program details can change annually.
Patient Assistance Program for Uninsured or Underinsured
Lilly’s Patient Assistance Program (PAP) provides Mounjaro at no cost to qualifying uninsured or underinsured patients who meet specific income guidelines. The program is designed for U.S. residents who lack coverage or whose insurance does not cover the medication.
Income limits are typically set at 400–500% of the federal poverty level, depending on household size. Applicants must submit proof of income, a prescription, and other documentation through the Lilly Cares website or by phone.
Approval usually takes 2–4 weeks, and medication is shipped directly to the patient or their pharmacy. The program covers a 12-month supply with annual reapplication required. It does not cover copays for insured patients.
Discount Cards and Pharmacy Savings Programs
Several third-party discount cards can lower the cash price for uninsured patients when manufacturer programs are not an option. GoodRx, SingleCare, and similar services often bring the price down to $900–$1,050 per month at participating pharmacies.
These cards are free to use and do not require insurance. Savings vary by location and pharmacy chain—Walmart, Costco, and some independent pharmacies frequently show the lowest discounted rates.
Always compare prices online before heading to the pharmacy. Some cards work better at certain chains, so checking multiple platforms can save an extra $50–$100 per fill.
Cost Comparison: Mounjaro vs. Similar Medications
Out-of-pocket costs without insurance differ across popular GLP-1 medications. Here is a quick 2026 snapshot of approximate cash prices for a one-month supply.
| Medication | Active Ingredient | Approximate Cash Price (1-month) | Notes on Savings Programs |
|---|---|---|---|
| Mounjaro | Tirzepatide | $1,060–$1,135 | Strong manufacturer savings card & PAP |
| Ozempic | Semaglutide | $950–$1,050 | Similar Lilly savings card & assistance |
| Wegovy | Semaglutide | $1,300–$1,400 | Higher list price; limited PAP eligibility |
| Trulicity | Dulaglutide | $900–$1,000 | GoodRx often brings it lower |
Mounjaro’s list price falls in the middle of the GLP-1 range, but its manufacturer savings programs make it one of the more affordable options for eligible patients paying cash or with partial coverage.
Practical Ways to Lower Your Monthly Cost
Call Lilly’s support line or visit their website to check eligibility for the savings card or Patient Assistance Program right away. Many patients qualify even if they initially think they do not.
Shop around at different pharmacies using discount card apps. Prices can vary by $100 or more between chains in the same city. Ask the pharmacist if they offer cash-pay discounts or match online prices.
Consider a 90-day supply if your doctor writes it that way—some pharmacies reduce the per-month cost slightly for larger fills. Avoid buying from unverified online sources claiming “generic” versions, as compounded products carry safety risks and are not FDA-approved.
What to Do If You Can’t Afford Mounjaro
Talk openly with your doctor about cost barriers. They may adjust the dose, switch to a less expensive GLP-1 (such as Trulicity or a generic alternative), or combine with older, lower-cost medications like metformin or a sulfonylurea.
Community health centers, free clinics, and some state assistance programs offer sliding-scale or low-cost diabetes care, including medications. Local nonprofit organizations sometimes help with pharmacy costs for chronic conditions.
If Mounjaro remains out of reach, lifestyle changes—consistent calorie control, regular physical activity, and carbohydrate management—still provide meaningful blood sugar and weight benefits while you explore long-term affordability solutions.
Summary
Without insurance, Mounjaro costs approximately $1,060–$1,135 per month (four-week supply) at retail pharmacies in 2026. That full price applies to uninsured patients or those whose plans exclude coverage. Eli Lilly’s savings card can drop the cost to $25 per fill for eligible commercially insured individuals, while the Patient Assistance Program offers free medication to qualifying uninsured or underinsured patients who meet income requirements. Third-party discount cards and pharmacy shopping can shave $50–$200 off the cash price for those who do not qualify for manufacturer help. Discuss affordability openly with your doctor early—they can guide you toward the most suitable treatment plan and connect you with every available savings resource so cost does not become a barrier to better health.
FAQ
How much does a one-month supply of Mounjaro cost without insurance?
A four-week carton of Mounjaro typically costs $1,060–$1,135 at U.S. retail pharmacies in 2026 when paying full cash price. Prices vary slightly by location and pharmacy chain. This amount applies before any discount cards or assistance programs are used.
Can I get Mounjaro for $25 a month without insurance?
No—the $25 copay from Eli Lilly’s savings card is available only to patients with commercial (private) insurance who meet eligibility rules. Uninsured individuals cannot use the card. The Patient Assistance Program may provide free medication if you qualify based on income and lack of coverage.
Does GoodRx or similar discount cards lower the price of Mounjaro?
Yes, GoodRx, SingleCare, and comparable cards often reduce the cash price to $900–$1,050 per month at participating pharmacies. These free cards require no insurance and work best when compared across multiple pharmacies in your area. Savings are usually less dramatic than manufacturer programs.
Who qualifies for free Mounjaro through Eli Lilly’s assistance program?
The Patient Assistance Program helps uninsured or underinsured U.S. residents who meet income guidelines (typically up to 400–500% of the federal poverty level) and have a valid prescription for an approved use. You must submit income proof and other documents. Approval usually takes 2–4 weeks.
What should I do if I can’t afford Mounjaro even with discounts?
Talk to your doctor about lower-cost alternatives such as Trulicity, other GLP-1 options, or older diabetes medications like metformin. Explore community clinics, state assistance programs, or nonprofit support for chronic conditions. Your provider can help tailor a plan that fits your budget while still controlling blood sugar effectively.

Dr. Hamza is a medical content reviewer with over 12+ years of experience in healthcare research and patient education. He specializes in evidence-based health information, medications, and chronic conditions. His reviews are grounded in trusted medical sources and current clinical guidelines to ensure accuracy, transparency, and reliability. Content reviewed by Dr. Hamza is intended for educational purposes and is not a substitute for professional medical advice.